The aim of this scoping review is to assess the current evidence regarding periprosthetic shoulder infection to inform development of evidence and consensus-based guidelines.
Methods
A search of Medline, Embase and PubMed was performed; two authors screened the results independently for inclusion.
Results
Totally 88 studies were included. Incidence of periprosthetic shoulder infection ranged from 0.7% to 7%. The most common organisms to cause periprosthetic shoulder infection were Propionibacterium acnes, Staphylococcus aureus, Staphylococcus epidermidis and coagulase-negative Staphylococcus. Male gender and younger age are the most reported risk factors. Erythrocyte sedimentation rate, C-reactive protein and serum/synovial biomarkers had limited diagnostic accuracy. Thirty-nine studies reported the outcome of surgical management of periprosthetic shoulder infection. Eradication rates vary from 54% to 100% for debridement procedures; 66–100% for permanent spacers; 50–100% following single-stage revision; 60–100% following two-stage revision; and 66–100% following resection arthroplasty.
Conclusion
There is wide heterogeneity in study designs and outcomes of studies are often contradictory and due to issues with methodology and small sample sizes the optimal pathways for diagnosis and management cannot be determined from this review. Future research should be based on larger cohorts and randomised trials where feasible to provide more valid research for guiding future treatment of periprosthetic shoulder infection.
FranceschiniVChillemiC. Periprosthetic shoulder infection. Open Orthop J2013; 7: 243–249.
2.
SeitzWH. Shoulder-joint infection: diagnosis and management. Semin Arthroplasty2011; 22: 42–47.
3.
National Joint Registry for England W, Northern Ireland and Isle of Man. 13th Annual Report. 2016.
4.
ParviziJZmistowskiBBerbariEFet al.New definition for periprosthetic joint infection: from the workgroup of the Musculoskeletal Infection Society. Clin Orthop Rel Res2011; 469: 2992–2994.
5.
PadegimasEMMaltenfortMRamseyMLet al.Periprosthetic shoulder infection in the United States: incidence and economic burden. J Shoulder Elbow Surg2015; 24: 741–746.
6.
KurtzSMLauEWatsonHet al.Economic burden of periprosthetic joint infection in the United States. J Arthroplasty2012; 27(8 suppl): 61–5.e1.
7.
AlpEGuneyACevahirFet al.Incidence and economic burden of prosthetic joint infections in a university hospital: a report from a middle-income country. J Infect Public Health2016; 9: 494–498.
8.
OuzzaniMHammadyHFedorowiczZet al.Rayyan – a web and mobile app for systematic reviews. Syst Rev2016, pp. 5–5.
9.
GeorgeDAVolpinAScarponiSet al.Does exchange arthroplasty of an infected shoulder prosthesis provide better eradication rate and better functional outcome, compared to a permanent spacer or resection arthroplasty? a systematic review orthopedics and biomechanics. BMC Musculoskelet Disord2016; 17: 52–52.
10.
Marcheggiani MuccioliGMHuriGGrassiAet al.Surgical treatment of infected shoulder arthroplasty. A systematic review. Intl Orthop2017; 41: 823–830.
11.
NelsonGNDavisDENamdariS. Outcomes in the treatment of periprosthetic joint infection after shoulder arthroplasty: a systematic review. J Shoulder Elbow Surg2016; 25: 1337–1345.
12.
ZumsteinMAPinedoMOldJet al.Problems, complications, reoperations, and revisions in reverse total shoulder arthroplasty: a systematic review. J Shoulder Elbow Surg2011; 20: 146–157.
13.
AchermannYSahinFSchwyzerHet al.Characteristics and outcome of 16 periprosthetic shoulder joint infections. Infection2013; 41: 613–620.
14.
AibinderWRSchochBSCofieldRHet al.Safety and efficacy of shoulder arthroplasty following lower extremity periprosthetic joint infection. J Shoulder Elbow Surg2017; 26: 79–84.
15.
AmaravathiRSKanyJMeletMet al.Analysis of infection in shoulder arthroplasty: a multicentre study. Europ J Orthop Surg Traumatol2012; 22: 145–150.
16.
AssenmacherATAlentorn-GeliESanchez-SoteloJet al.Two-stage reimplantation for the treatment of deep infection after shoulder arthroplasty. J Shoulder Elbow Surg2005; 26: e163–e163.
17.
BeekmanPDAKatusicDBerghsBMet al.One-stage revision for patients with a chronically infected reverse total shoulder replacement. J Bone Joint Surg Ser B2010; 92: 817–822.
18.
BramanJPSpragueMBishopJet al.The outcome of resection shoulder arthroplasty for recalcitrant shoulder infections. J Shoulder Elbow Surg2006; 15: 549–553.
CheungEVSperlingJWCofieldRH. Infection associated with hematoma formation after shoulder arthroplasty. Clin Orthop Relat Res2008; 466: 1363–1367.
21.
CoffeyMJElyEECrosbyLA. Treatment of glenohumeral sepsis with a commercially produced antibiotic-impregnated cement spacer. J Shoulder Elbow Surg2010; 19: 868–873.
22.
CuffDJViraniNALevyJet al.The treatment of deep shoulder infection and glenohumeral instability with debridement, reverse shoulder arthroplasty and post-operative antibiotics. J Bone Joint Surg Ser B2008; 90: 336–342.
23.
DennisonTAlentorn-GeliEAssenmacherATet al.Management of acute or late hematogenous infection after shoulder arthroplasty with irrigation, debridement, and component retention. J Shoulder Elbow Surg2017; 26: 73–78.
24.
DodsonCCCraigEVCordascoFAet al.Propionibacterium acnes infection after shoulder arthroplasty: a diagnostic challenge. J Shoulder Elbow Surg2010; 19: 303–307.
25.
FalconerTMBabaMKruseLMet al.Contamination of the surgical field with Propionibacterium acnes in primary shoulder arthroplasty. J Bone Joint Surg2016; 98-A: 1722–1728.
26.
ForuriaAMFoxTJSperlingJWet al.Clinical meaning of unexpected positive cultures (UPC) in revision shoulder arthroplasty. J Shoulder Elbow Surg2013; 22: 620–627.
27.
GormanMTCrosbyLA. Treatment of deep infection after total shoulder arthroplasty with an antibiotic-impregnated cement spacer. Tech Shoulder Elbow Surg2006; 7: 82–85.
28.
GrossoMJSabesanVJHoJCet al.Reinfection rates after 1-stage revision shoulder arthroplasty for patients with unexpected positive intraoperative cultures. J Shoulder Elbow Surg2012; 21: 754–758.
29.
HattrupSJRenfreeKJ. Two-stage shoulder reconstruction for active glenohumeral sepsis. Orthopedics2010; 33: 20–20.
30.
HsuJEGorbatyJDWhitneyIJet al.Single-stage revision is effective for failed shoulder arthroplasty with positive cultures for propionibacterium. J Bone Joint Surg Am2016; 98: 2047–2051.
31.
InceASeemannKFrommeltLet al.One-stage exchange shoulder arthroplasty for peri-prosthetic infection. J Bone Joint Surg Br2005; 87: 814–818.
32.
JawaAShiLO’BrienTet al.Prosthesis of antibiotic-loaded acrylic cement (PROSTALAC) use for the treatment of infection after shoulder arthroplasty. J Bone Joint Surg Ser A2011; 93: 2001–2009.
KlatteTOJunghansKAl-KhateebHet al.Single-stage revision for peri-prosthetic shoulder infection: outcomes and results. Bone Joint J2013; 95: 391–395.
35.
LevyJCTripletJEverdingN. Use of a functional antibiotic spacer in treating infected shoulder arthroplasty. Orthopedics2015; 38: e512–e519.
36.
LevyOIyerSAtounEet al.Propionibacterium acnes: an underestimated etiology in the pathogenesis of osteoarthritis?J Shoulder Elbow Surg2013; 22: 505–511.
37.
MahureSAMollonBYuSet al.Definitive treatment of infected shoulder arthroplasty with a cement spacer. Orthopedics2016; 39: e924–e930.
38.
MatsenFA3rdRussSMBertelsenAet al.Propionibacterium can be isolated from deep cultures obtained at primary arthroplasty despite intravenous antimicrobial prophylaxis. J Shoulder Elbow Surg2015; 24: 844–847.
39.
McGoldrickEMcElvanyMDButler-WuSet al.Substantial cultures of Propionibacterium can be found in apparently aseptic shoulders revised three years or more after the index arthroplasty. J Shoulder Elbow Surg2015; 24: 31–35.
40.
PhadnisJGordonDKrishnanJet al.Frequent isolation of Propionibacterium acnes from the shoulder dermis despite skin preparation and prophylactic antibiotics. J Shoulder Elbow Surg2016; 25: 304–310.
41.
RichardsJInacioMCSBeckettMet al.Patient and procedure-specific risk factors for deep infection after primary shoulder arthroplasty. Clin Orthop Rel Res2014; 472: 2809–2815.
42.
RomanoCLGalaLLogolusoNet al.Septic shoulder prosthesis: Surgical treatment and results of a consecutive series of 20 cases. J Orthop Traumatol2011; 12: S28–S29.
SinghJASperlingJWSchleckCet al.Periprosthetic infections after total shoulder arthroplasty: a 33-year perspective. J Shoulder Elbow Surg2012; 21: 1534–1541.
47.
StineIALeeBZalavrasCGet al.Management of chronic shoulder infections utilizing a fixed articulating antibiotic-loaded spacer. J Shoulder Elbow Surg2010; 19: 739–748.
48.
StricklandJPSperlingJWCofieldRH. The results of two-stage re-implantation for infected shoulder replacement. J Bone Joint Surg Br2008; 90: 460–465.
49.
ThemistocleousGZalavrasCStineIet al.Prolonged implantation of an antibiotic cement spacer for management of shoulder sepsis in compromised patients. J Shoulder Elbow Surg2007; 16: 701–705.
50.
TwissTJCrosbyLA. Treatment of the infected total shoulder arthroplasty with antibiotic-impregnated cement spacers. Semin Arthroplasty2010; 21: 204–208.
51.
WangBToyeBDesjardinsMet al.A 7-year retrospective review from 2005 to 2011 of Propionibacterium acnes shoulder infections in Ottawa, Ontario, Canada. Diagn Microbiol Infect Dis2013; 75: 195–199.
52.
YianEChanPHNavarroRAet al.Surgeon-controllable risk factors for periprosthetic infection: an analysis of 8,056 shoulder arthroplasties. J Shoulder Elbow Surg2017; 26: e160–e160.
53.
ZavalaJAClarkJCKissenberthMJet al.Management of deep infection after reverse total shoulder arthroplasty: a case series. J Shoulder Elbow Surg2012; 21: 1310–1315.
54.
BalaAPenroseCTVisgaussJDet al.Total shoulder arthroplasty in patients with HIV infection: complications, comorbidities, and trends. J Shoulder Elbow Surg2016; 25: 1971–1979.
55.
TrappeyGJtO’ConnorDPEdwardsTB. What are the instability and infection rates after reverse shoulder arthroplasty?Clin Orthop Relat Res2010; 469: 2505–2511.
56.
MagnanBBondiMVecchiniEet al.A preformed antibiotic-loaded spacer for treatment for septic arthritis of the shoulder. Musculoskelet Surg2014; 98: 15–20.
57.
AnakwenzeOFokinAChocasMet al.Complications in total shoulder and reverse total shoulder arthroplasty by body mass index. J Shoulder Elbow Surg2017; 30: 30–30.
58.
CosteJSReigSTrojaniCet al.The management of infection in arthroplasty of the shoulder. J Bone Joint Surg Br2004; 86: 69–69.
59.
EverhartJSBishopJYBarlowJD. Medical comorbidities and perioperative allogeneic red blood cell transfusion are risk factors for surgical site infection after shoulder arthroplasty. J Shoulder Elbow Surg2017; 26: 1922–1930.
60.
FlorschutzAVLanePDCrosbyLA. Infection after primary anatomic versus primary reverse total shoulder arthroplasty. J Shoulder Elbow Surg2015; 24: 1296–1301.
61.
GhijselingsSStuyckJDebeerPProf. Surgical treatment algorithm for infected shoulder arthroplasty: a retrospective analysis of 17 cases. Acta Orthop Belg2013; 79: 626–635.
62.
HattaTWerthelJDWagnerERet al.Effect of smoking on complications following primary shoulder arthroplasty. J Shoulder Elbow Surg2017; 26: 1–6.
63.
HouCGuptaAChenMet al.How do revised shoulders that are culture positive for Propionibacterium differ from those that are not?J Shoulder Elbow Surg2015; 24: 1427–1432.
64.
JacquotASirveauxFRocheOet al.Surgical management of the infected reversed shoulder arthroplasty: a French multicenter study of reoperation in 32 patients. J Shoulder Elbow Surg2015; 24: 1713–1722.
LorenzettiAJWongworawatMDJobeCMet al.Cyanoacrylate microbial sealant may reduce the prevalence of positive cultures in revision shoulder arthroplasty. Clin Orthop Rel Res2013; 471: 3225–3229.
67.
LovalloJHelmingJJafariSMet al.Intraoperative intra-articular injection of gentamicin: will it decrease the risk of infection in total shoulder arthroplasty?J Shoulder Elbow Surg2014; 23: 1272–1276.
68.
MaccioniCBWoodbridgeABBalestroJCet al.Low rate of Propionibacterium acnes in arthritic shoulders undergoing primary total shoulder replacement surgery using a strict specimen collection technique. J Shoulder Elbow Surg2015; 24: 1206–1211.
69.
MorrisBJO’ConnorDPTorresDet al.Risk factors for periprosthetic infection after reverse shoulder arthroplasty. J Shoulder Elbow Surg2015; 24: 161–166.
70.
NowinskiRJGillespieRJShishaniYet al.Antibiotic-loaded bone cement reduces deep infection rates for primary reverse total shoulder arthroplasty: a retrospective, cohort study of 501 shoulders. J Shoulder Elbow Surg2012; 21: 324–328.
71.
OrtmaierRReschHHitzlWet al.Treatment strategies for infection after reverse shoulder arthroplasty. Eur J Orthop Surg Traumatol2014; 24: 723–731.
72.
RomanoCLBorensOMontiLet al.What treatment for periprosthetic shoulder infection? Results from a multicentre retrospective series. Int Orthop2012; 36: 1011–1017.
73.
SperlingJWHawkinsRJWalchGet al.Complications in total shoulder arthroplasty. J Bone Joint Surg Am2001; 95: 563–569.
74.
VerhelstLStuyckJBellemansJet al.Resection arthroplasty of the shoulder as a salvage procedure for deep shoulder infection: does the use of a cement spacer improve outcome?J Shoulder Elbow Surg2011; 20: 1224–1233.
75.
WalchGBacleGLadermannAet al.Do the indications, results, and complications of reverse shoulder arthroplasty change with surgeon’s experience?J Shoulder Elbow Surg2012; 21: 1470–1477.
76.
WeberPUtzschneiderSSadoghiPet al.Management of the infected shoulder prosthesis: a retrospective analysis and review of the literature. Int Orthop2010; 35: 365–373.
77.
WernerBCCancienneJMBurrusMTet al.The timing of elective shoulder surgery after shoulder injection affects postoperative infection risk in Medicare patients. J Shoulder Elbow Surg2016; 25: 390–397.
78.
WerthelJDHattaTSchochBet al.Is previous nonarthroplasty surgery a risk factor for periprosthetic infection in primary shoulder arthroplasty?J Shoulder Elbow Surg2017; 26: 635–640.
79.
ZhangALFeeleyBTSchwartzBSet al.Management of deep postoperative shoulder infections: is there a role for open biopsy during staged treatment?J Shoulder Elbow Surg2015; 24: e15–e20.
80.
DilisioMFMillerLRWarnerJJPet al.Arthroscopic tissue culture for the evaluation of periprosthetic shoulder infection. J Bone Joint Surg Am2014; 96: 1952–1958.
81.
FrangiamoreSJSalehAGrossoMJet al.Neer Award 2015: analysis of cytokine profiles in the diagnosis of periprosthetic joint infections of the shoulder. J Shoulder Elbow Surg2017; 26: 186–196.
82.
FrangiamoreSJSalehAGrossoMJet al.Alpha-defensin as a predictor of periprosthetic shoulder infection. J Shoulder Elbow Surg2015; 24: 1021–1027.
83.
FrangiamoreSJSalehAKovacMFet al.Synovial fluid interleukin-6 as a predictor of periprosthetic shoulder infection. J Bone Joint Surg Am2015; 97: 63–70.
84.
GrossoMJFrangiamoreSJRicchettiETet al.Sensitivity of frozen section histology for identifying Propionibacterium acnes infections in revision shoulder arthroplasty. J Bone Joint Surg Am2014; 96: 442–447.
85.
GrossoMJFrangiamoreSJSalehAet al.Poor utility of serum interleukin-6 levels to predict indolent periprosthetic shoulder infections. J Shoulder Elbow Surg2014; 23: 1277–1281.
86.
MarmorSBauerTDesplacesNet al.Multiplex antibody detection for noninvasive genus-level diagnosis of prosthetic joint infection. J Clin Microbiol2016; 54: 1065–1073.
87.
NelsonGNPaxtonESNarzikulAet al.Leukocyte esterase in the diagnosis of shoulder periprosthetic joint infection. J Shoulder Elbow Surg2015; 24: 1421–1426.
PiperKEJacobsonMJCofieldRHet al.Microbiologic diagnosis of prosthetic shoulder infection by use of implant sonication. J Clin Microbiol2009; 47: 1878–1884.
90.
TashjianRZGrangerEKZhangY. Utility of prerevision tissue biopsy sample to predict revision shoulder arthroplasty culture results in at-risk patients. J Shoulder Elbow Surg2017; 26: 197–203.
91.
VillacisDMerrimanJAYalamanchiliRet al.Serum interleukin-6 as a marker of periprosthetic shoulder infection. J Bone Joint Surg Am2014; 96: 41–45.
92.
CraneJKHohmanDWNodzoSRet al.Antimicrobial susceptibility of Propionibacterium acnes isolates from shoulder surgery. Antimicrob Agents Chemother2013; 57: 3424–3426.
93.
NodzoSRHohmanDWCraneJKet al.Hemolysis as a clinical marker for Propionibacterium acnes orthopedic infection. Am J Orthop2014; 43: E93–E97.
94.
SmucnyMMenendezMERingDet al.Inpatient surgical site infection after shoulder arthroplasty. J Shoulder Elbow Surg2015; 24: 747–753.
95.
HatchMDDanielsSDGlerumKMet al.The cost-effectiveness of vancomycin for preventing infections following shoulder arthroplasty: a break even analysis. J Shoulder Elbow Surg2017; 26: e144–e145.
ZimmerliWTrampuzAOchsnerPE. Prosthetic-joint infections. N Engl J Med2004; 351: 1645–1654.
101.
TrampuzAZimmerliW. Prosthetic joint infections: update in diagnosis and treatment. Swiss Med Wkly2005; 135: 243–251.
102.
CorvecSpPortilloMaEPasticciBMet al.Epidemiology and new developments in the diagnosis of prosthetic joint infection. Int J Artif Organs2012; 35: 923–934.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
